痴呆症的病理生理学痴呆症的病理生理学
1MBBS, Consultant Geriatrician, Department of Aged Care, The Royal Melbourne Hospital, Melbourne, Vic; Clinical Research Fellow, Population Health and Immunity Division, the Walter and Eliza Hall Institute of Medical Research, Melbourne, Vic.
Australian journal of general practice
|August 2, 2023
概括
痴呆症是一个主要的公共卫生问题,涉及复杂的神经生物学. 了解阿尔茨海默病等常见痴呆症类型的病理生理学对于开发有效的治疗方法和生物标志物至关重要.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 病理生理学 病理生理学
背景情况:
- 痴呆症是一个重要的全球健康问题,影响着数百万.
- 了解痴呆症的神经生物学和病理生理学是治疗开发的关键.
研究的目的:
- 审查常见晚发性痴呆症的病理生理学.
- 突出痴呆症生物标志物研究的进展.
主要方法:
- 关于痴呆症病理生理过程的文献综述.
- 综述常见的痴呆类型:阿尔茨海默病,勒维体痴呆,血管痴呆和前性痴呆.
主要成果:
- 痴呆症的病理生理学涉及蛋白质错折 (例如,粉样蛋白-β斑块,神经纤维状) 和脑血管疾病.
- 混合神经病理在老年痴呆症患者中很常见,具有临床意义.
结论:
- 对痴呆症病理生理学和生物标志物的持续研究至关重要.
- 了解混合神经病理可能会改善临床管理和治疗策略.
相关概念视频
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Alzheimer's Disease: Overview
522
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
522
Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
748
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
748
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Alzheimer's Disease: Treatment
218
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
218


